Advancing technologies, evolving customer-centric platforms, and a changing regulatory landscape are opening doors to disruptive digital innovation in the financial sector. Retail banking is no longer solely branch-based; managing your finances can be conducted in many ways, including using mobile platforms. The use of algorithms, big data, and blockchain means that the role of the intermediary is changing; banks now face competition from other intermediaries in their core business, which may have antitrust implications.
In this free, one-hour webinar, held on Thursday, 10 September, at 3:00–4:00 pm EDT, NERA Associate Directors Dr. Alan Grant, Dr. Sheng Li, Dr. Will Taylor, and Morrison & Foerster Partner Michael Miller will discuss:
- The economic factors and antitrust concerns of mobile payment platforms;
- Key takeaways from the Paymark/Ingenico merger;
- Bank collective negotiations with Apple; and
- The impact of technology on the financial services sector.
Application for 1 credit hour of CLE is currently pending approval in California.Dr. Alan Grant is an Associate Director in NERA’s Antitrust and Competition Practice. His background spans the fields of antitrust and financial economics. Dr. Grant has consulted on issues in commercial and antitrust damages cases, antitrust class actions, and breach of contract disputes. He also has experience analyzing the competitive effects of mergers. Dr. Grant’s work in securities includes valuations involving hedge funds, private equity funds, healthcare assets, and real estate. He has worked on a number of securities litigation projects, including those related to insider trading, hedge funds, equity trading activity, royalty disputes, and compensation disputes.
Dr. Sheng Li is an Associate Director in NERA’s Antitrust and Competition Practice, and its Intellectual Property Practice, where he conducts research and economic analysis in antitrust and intellectual property matters. He has evaluated damages theories in cases involving alleged monopolization, exclusive dealing, and price fixing. Dr. Li has also assessed damages arising from patent infringement and issues related to antitrust patent misuse. He has analyzed competitive issues in a variety of industries, including medical devices, auto insurance, transoceanic shipping, and prescription eyewear.
Dr. Will Taylor is an Associate Director in NERA’s Antitrust and Competition; Energy; and Communications, Media, and Internet Practices. He provides expert analysis and advice to clients across New Zealand and Australia in matters involving antitrust, regulatory, and financial economics. Dr. Taylor regularly assists clients dealing with complex regulatory issues, merger and abuse of market power investigations, and quantum disputes in litigation and arbitration. These studies typically assess competition and, if it is lacking, consider regulatory interventions. Dr. Taylor’s expertise in financial economics is brought to bear in quantum disputes regarding infrastructure access, fair trading and misrepresentation claims, and commercial damages arbitrations and litigation.
Michael Miller is a Partner at Morrison & Foerster. He regularly represents clients in managing antitrust risk in complex transactional and other business matters, including strategy and structuring of transactions to avoid antitrust risk and achieve strategic business objectives, and US and multinational merger notification and review. He is regularly called on to help clients overcome complex challenges in both federal and state courts and in regulatory proceedings. Mr. Miller’s practice includes all aspects of complex financial services, antitrust, privacy, and commercial litigation, and he is frequently consulted on related regulatory matters and in merger control proceedings in a variety of jurisdictions.